RecruitingNCT06690983

Tau PET/CT in Various Tau-Related Disease Patients

Sponsor

Tianjin Medical University

Enrollment

500 participants

Start Date

Aug 1, 2018

Study Type

OBSERVATIONAL

Conditions

Neurodegenerative Diseases Neurodegeneration Tauopathies

Summary

To evaluate the potential usefulness of 18F-S16/T807 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various Tau-related disease patients.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 18F-S16/T807 for people with neurodegeneration, neurodegenerative diseases, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.